Datasets:

iambigmarn

/

common_drugs

like 0

Flagyl is an antibiotic that is used to treat bacterial infections of the vagina, stomach, liver, skin, joints, brain and spinal cord, lungs, heart, or bloodstream. Flagyl is also used to treat trichomoniasis, a sexually transmitted disease caused by a parasite. Usually both sexual partners are treated at the same time, even if one has no symptoms. Do not use Flagyl to treat any conditions that have not been checked by your doctor.

Flecainide is a Class IC anti-arrhythmic that is used in certain situations to prevent serious heart rhythm disorders. Flecainide may also be used for purposes not listed in this medication guide.

Flexeril is a muscle relaxant. It works by blocking nerve impulses (or pain sensations) that are sent to your brain. Flexeril is used together with rest and physical therapy to treat skeletal muscle conditions such as pain, injury, or spasms. Flexeril may also be used for purposes not listed in this medication guide.

Flomax (tamsulosin) belongs to in a class of medications called alpha blockers. It works by relaxing the muscles in the prostate and bladder so that urine can flow easily. Flomax capsules are used in men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia or BPH) which include difficulty urinating (hesitation, dribbling, weak stream, and incomplete bladder emptying), painful urination, and urinary frequency and urgency. Flomax capsules are not approved for use in women or children.

Flonase is a nasal spray containing fluticasone propionate. Fluticasone propionate is a corticosteroid that prevents the release of substances in the body that cause inflammation. Flonase Nasal Spray is used to treat nasal congestion, sneezing, runny nose, and itchy or watery eyes caused by seasonal or year-round allergies. Flonase is for use in adults and children who are at least 4 years old and is available without a prescription.

Flonase Allergy Relief (for the nose) is a steroid medicine that is used to treat nasal congestion, sneezing, runny nose, and itchy or watery eyes caused by seasonal or year-round allergies. The Xhance brand of Flonase Allergy Relief is for use only in adults. Veramyst may be used in children as young as 2 years old. Flonase is for use in adults and children who are at least 4 years old. Flonase Allergy Relief may also be used for purposes not listed in this medication guide.

Flovent is a corticosteroid. It prevents the release of substances in the body that cause inflammation. Flovent is used to prevent asthma attacks. This medicine will not treat an asthma attack that has already begun. Flovent is sometimes used together with steroid medicine taken by mouth. This medicine is for use in adults and children who are at least 4 years old.

Flovent HFA is a steroid that is used to prevent asthma attacks in adults and children. This medicine is sometimes used together with steroid medicine taken by mouth. Flovent brands of fluticasone inhalation may be used in children as young as 4 years old. Arnuity Ellipta should not be used in children younger than 5 years old, and ArmonAir should not be used in anyone younger than 12 years old. Fluticasone may also be used for purposes not listed in this medication guide.

Fluconazole is a prescription azole antifungal medication that may be used to treat serious fungal or yeast infections including those that affect the vagina, mouth or throat, lungs, bladder, or blood. It is available as an oral tablet, suspension, or injectable form. Fluconazole may also be used to prevent fungal infections in people with a weak immune system caused by cancer or cancer treatment including radiation therapy, bone marrow transplant, conditions such as AIDS, or children on life support (extracorporeal membrane oxygenation [ECMO]). Fluconazole works by targeting a key enzyme (lanosterol 14-alpha-demethylase) responsible for building a crucial cell wall component (ergosterol) in fungi. By blocking this enzyme, Fluconazole prevents the fungus from forming a normal cell wall, leading to the buildup of abnormal sterols. These abnormal sterols weaken the fungal cell wall, hindering its growth. Fluconazole's mechanism of action means it has a much greater effect on this enzyme in fungi compared to the same enzyme in human cells. This selectivity helps minimize side effects. Fluconazole was first FDA approved on January 29, 1990. Brand names for fluconazole include Diflucan and generic fluconazole is available.

Fludrocortisone is a steroid that helps reduce inflammation in the body. Fludrocortisone is used to treat conditions in which the body does not produce enough of its own steroids, such as Addison's disease, and salt-losing adrenogenital syndrome. Fludrocortisone may also be used for purposes not listed in this medication guide.

FluMist Quadrivalent is a nasal spray flu vaccine used to prevent infection against four strains of the influenza virus. FluMist works by exposing you to a small dose of the weakened influenza virus, which helps your body to develop immunity to the disease. FluMist Quadrivalent can be used for people from 2 to 49 years of age. FluMist Quadrivalent 2023-2024 Formula contains two influenza A subtype viruses (A/H1N1 strain,  A/H3N2 strain) and two influenza B strains (B/Yamagata/16/88 lineages, B/Victoria/2/87 lineages). The vaccine is redeveloped each year to contain specific strains of activated (live) flu virus that are recommended by public health officials for that year. Influenza (commonly known as "the flu") is a serious disease caused by a virus. Influenza virus can spread from one person to another through small droplets of saliva that are expelled into the air when an infected person coughs or sneezes. The virus can also be passed through contact with objects the infected person has touched, such as a door handle or other surfaces.

Fluocinonide is a high to super-high potency topical corticosteroid that may be used to reduce inflammation and itching caused by skin conditions that respond to topical corticosteroids, such as plaque psoriasis. It is approved for adults and children over the age of 12 years and should not be used for more than two consecutive weeks. The potency varies depending on the product and its concentration. Fluocinonide topical is available in a cream, gel, ointment, and solution. Fluocinonide was first approved on June 30, 1971.

Treatment of adenocarcinoma of the colon, rectum, breast, stomach, and pancreas. Adjunct to surgery for the treatment of various solid tumors (e.g., adenocarcinoma of the colon, rectal carcinoma). Drug of choice (combined with leucovorin or levoleucovorin and other drugs [e.g., irinotecan, oxaliplatin]) for advanced colorectal cancer in the adjuvant or metastatic setting. Doublet regimens (i.e., fluorouracil, oxaliplatin, and leucovorin or levoleucovorin [FOLFOX]; fluorouracil, irinotecan, and leucovorin or levoleucovorin [FOLFIRI]; capecitabine and oxaliplatin [CapeOx; CapOx]) are the current standard of care for the adjuvant or palliative treatment of advanced colorectal cancer. Fluorouracil combined with leucovorin or levoleucovorin is an acceptable treatment option in limited-resource settings or in patients unable to tolerate a doublet regimen. Weekly schedule of fluorouracil/leucovorin (high-dose leucovorin or Roswell Park regimen) has equal efficacy as monthly schedule (low-dose or Mayo Clinic schedule), but the weekly schedule is a preferred regimen for adjuvant therapy because of ease of use and less toxicity. (See Colorectal Cancer under Dosage and Administration.) Bimonthly, continuous IV infusion schedule of fluorouracil/leucovorin (LV5FU2 or deGramont regimen) also evaluated as adjuvant therapy and shown to be safer than direct IV injection regimen of these drugs. Simplified version of this regimen also evaluated. (See Colorectal Cancer under Dosage and Administration.) Role of regional adjuvant therapy (e.g., portal vein or hepatic artery infusion† [off-label]) for liver metastases requires further elucidation. Leucovorin and levoleucovorin enhance cytotoxicity, potentiate fluorouracil antineoplastic activity, and improve response for advanced colorectal carcinoma treatment. Leucovorin and levoleucovorin may potentiate risk of fluorouracil GI toxicity (e.g., diarrhea, nausea, stomatitis, vomiting) and myelosuppression. Combined with other drugs (e.g., cyclophosphamide, doxorubicin, methotrexate) as an adjunct to surgery and for metastatic breast cancer. Decision regarding use of adjuvant endocrine therapy with or without sequential combination chemotherapy may be guided by prognostic tools, such as recurrence score based on 21-gene assay results, to predict absolute benefit of combination chemotherapy in addition to adjuvant endocrine therapy. Adjunct to surgery, may improve outcome. Has been used alone and in combination therapy (e.g., with cisplatin) for the treatment of localized or advanced esophageal cancer† [off-label]. Has been used in combination chemotherapy for metastatic or recurrent squamous cell carcinoma of the head and neck† [off-label]. Has been used in combination chemotherapy with radiation therapy for palliative treatment of unresectable locally advanced head and neck cancer, and for larynx preservation in locally advanced laryngeal or hypopharyngeal cancer. Used in combination with docetaxel and cisplatin as induction therapy prior to radiotherapy or chemoradiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck. Has been used in combination with cisplatin concurrently with radiation therapy for invasive cervical cancer† [off-label]. Metastatic or recurrent cervical cancer† [off-label]. Has been used alone or in combination regimens for the treatment of metastatic renal cell carcinoma†. Has been used for the treatment of carcinoid tumors†. Has been used as second-line therapy in the treatment of ovarian epithelial cancer†, including platinum-refractory disease. Also, cancers of the liver† (e.g., hepatoblastoma†).

Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) antidepressant. Fluoxetine inhibits the uptake of serotonin by a nerve cells (neurons) and helps people with depression, panic, anxiety, or obsessive-compulsive symptoms. Fluoxetine is a prescription medicine used to treat major depressive disorder, bulimia nervosa (an eating disorder), obsessive-compulsive disorder, panic disorder, and premenstrual dysphoric disorder (PMDD). Fluoxetine is sometimes used together with another medication called olanzapine (Zyprexa) to treat manic depression caused by bipolar disorder. This combination is also used to treat depression after at least 2 other medications have been tried without successful treatment of symptoms. If you also take olanzapine (Zyprexa), read the Zyprexa medication guide and all patient warnings and instructions provided with that medication.

Fluphenazine is a phenothiazine (FEEN-oh-THYE-a-zeen) antipsychotic medicine that is used to treat psychotic disorders such as schizophrenia. Fluphenazine may also be used for purposes not listed in this medication guide.

Flutamide is a nonsteroidal antiandrogen (testosterone blocker) medicine. Flutamide capsules are used to treat prostate cancer. Flutamide is given in combination with another medicine called a luteinizing (LOO-tee-in-ize-ing) hormone-releasing hormone, or LHRH. LHRH helps prevent the testicles from producing testosterone.

Fluticasone Propionate Cream, USP 0.05% is a medium potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Fluticasone Propionate Cream, USP 0.05% may be used with caution in pediatric patients 3 months of age or older. The safety and efficacy of drug use for longer than 4 weeks in this population have not been established. The safety and efficacy of Fluticasone Propionate Cream, USP 0.05% in pediatric patients below 3 months of age have not been established.

Fluticasone and salmeterol inhalation is a steroid and bronchodilator combination medicine that is used to prevent asthma attacks. It is also used to prevent flare-ups or worsening of chronic obstructive pulmonary disease (COPD) associated with chronic bronchitis and/or emphysema. In people with COPD, fluticasone and salmeterol is for long-term treatment. In people with asthma, fluticasone and salmeterol is for short-term treatment until symptoms are well controlled with with other medicines. Advair Diskus is for use in adults and children who are at least 4 years old. Advair HFA and AirDuo Respiclick are for use in adults and children who are at least 12 years old. Fluticasone and salmeterol may also be used for purposes not listed in this medication guide.

Fluticasone nasal (for the nose) is a steroid medicine that is used to treat nasal congestion, sneezing, runny nose, and itchy or watery eyes caused by seasonal or year-round allergies. The Xhance brand of fluticasone nasal is for use only in adults. Veramyst may be used in children as young as 2 years old. Flonase is for use in adults and children who are at least 4 years old. Fluticasone nasal may also be used for purposes not listed in this medication guide.

Fluvastatin is used together with diet to lower blood levels of "bad" cholesterol (low-density lipoprotein, or LDL), to increase levels of "good" cholesterol (high-density lipoprotein, or HDL), and to lower triglycerides (a type of fat in the blood). Fluvastatin is used to slow the build-up of plaque (fatty deposits) in your blood vessels. Fluvastatin is also used to lower the risk of heart complications in certain people with coronary heart disease. Fluvastatin is used in adults and children who are at least 10 years old. Fluvastatin may also be used for purposes not listed in this medication guide.

Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI). Fluvoxamine is used to treat symptoms of obsessive compulsive disorder (OCD) in adults and children at least 8 years old. Fluvoxamine may also be used for purposes not listed in this medication guide.

Focalin is a mild stimulant to the central nervous system. It affects chemicals in the brain that contribute to hyperactivity and impulse control. Focalin is a prescription medicine used to treat attention deficit hyperactivity disorder (ADHD). Focalin should be used as a part of a total treatment program for ADHD that may include counseling or other therapies.

Folic acid (vitamin B9) is a B vitamin supplement that may be used to prevent and treat folate deficiency (low blood levels of folate) that can cause megaloblastic anemia. Folic acid may also be used to control high levels of homocysteine, prevent serious birth defects in pregnant women or women who think they may be pregnant, and prevent methotrexate-induced folate deficiency in people prescribed methotrexate. Folic acid has been FDA approved since 1947.

Forteo is a man-made form of parathyroid hormone that exists naturally in the body. Teriparatide increases bone mineral density and bone strength, which may prevent fractures. Forteo is used to treat osteoporosis caused by menopause, steroid use, or gonadal failure. Forteo is for use when you have a high risk of bone fracture due to osteoporosis.

Fosamax is a bisphosphonate (bis FOS fo nayt) medicine that alters bone formation and breakdown in the body. This can slow bone loss and may help prevent bone fractures. Fosamax is used in women to treat or prevent osteoporosis caused by menopause and in men and women to treat osteoporosis caused by taking steroids. Fosamax is also used to increase bone mass in men who have osteoporosis, and to treat Paget's disease of bone in men and women.

Fosfomycin is an antibiotic that fights infection caused by bacteria. Fosfomycin is used to treat bladder infections. Fosfomycin may also be used for purposes not listed in this medication guide.

Fulvestrant is a hormone therapy you may be prescribed if you have certain types of breast cancer. Fulvestrant is an estrogen receptor antagonist that binds to estrogen receptors in breast cancer cells. The hormone estrogen encourages breast cancer cells to grow, and fulvestrant works by binding and blocking the estrogen receptor, which slows the growth of cancer. Fulvestrant was first approved by the FDA in 2002 after Phase 3 trials showed that the patients on fulvestrant took longer for their cancer to get worse, when compared to patients on Arimidex (anastrozole). It is approved to be used for certain types of breast cancer in women, so your doctor will only prescribe it for you if it has been shown to be effective for your type of cancer. It is given as an injection into your buttock muscle once a month, but your dose may change depending on how well it is working for you and if you are having side effects. You may also be given other medicines with fulvestrant to treat your breast cancer.

Furosemide is a loop diuretic used to treat fluid retention (edema) in people with congestive heart failure, liver disease, or a kidney disorder such as nephrotic syndrome. Furosemide is also used to treat high blood pressure (hypertension). Furosemide works by increasing the amount of urine the body makes, which helps reduce swelling and symptoms of fluid retention and helps lower high blood pressure. Furosemide tablets are sometimes called water pills as they increase how much you urinate. Furosemide is also known as frusemide in some countries. Furosemide became an FDA-approved medicine on July 1, 1966, and is available as tablets (Lasix), oral liquid, injection, and intravenous solution.

Fycompa is an anticonvulsant used to treat seizures in adults and children. Fycompa is used to treat partial onset seizures that may or may not develop into general seizures in people with epilepsy who are at least 4 years old. Fycompa is also used with other medications to treat primary generalized tonic-clonic (PGTC) seizures in patients 12 years of age and older.

Gabapentin (Neurontin, Gralise, Horizant) is a medicine used to treat partial seizures, nerve pain from shingles and restless leg syndrome. It works on the chemical messengers in your brain and nerves.  Gabapentin is from a group of medicines called anticonvulsants.  Different brands of gabapentin are not interchangeable and they are FDA approved for different conditions. Use only the brand and form of gabapentin your doctor has prescribed. Check your medicine each time you get a refill to make sure you receive the correct form.  Neurontin (gabapentin) is used to treat pain you may have from shingles (postherpetic nerve pain). It is also used with other seizure medicines for partial onset seizures in patients 3 years and older. Gralise (gabapentin) is only used for pain after having shingles (postherpetic nerve pain). It should not be used for any other medical condition. Horizant (gabapentin enacarbil) is an extended release tablet used to treat restless legs syndrome and for the pain from having shingles (postherpetic nerve pain). Generic brands of gabapentin capsules, USP are used for postherpetic nerve pain and for add on therapy for partial onset seizures in patients 3 years and older

Gabapentin enacarbil is used to treat moderate-to-severe primary Restless Legs Syndrome (RLS). RLS is a neurologic disorder that makes the legs feel uncomfortable. This results in an irresistible feeling of wanting to move your legs to make them comfortable. Gabapentin enacarbil is also used to manage a condition called postherpetic neuralgia, which is pain that occurs after shingles. This medicine is available only with your doctor's prescription.

Galantamine improves the function of nerve cells in the brain. It works by preventing the breakdown of a chemical called acetylcholine (ah see til KO leen). People with dementia usually have lower levels of this chemical, which is important for the processes of memory, thinking, and reasoning. Galantamine is used to treat mild to moderate Alzheimer's type dementia. Galantamine may also be used for purposes not listed in this medication guide.

Ganciclovir for Injection, USP is indicated for the treatment of cytomegalovirus (CMV) retinitis in immunocompromised adult patients, including patients with acquired immunodeficiency syndrome (AIDS) [see Clinical Studies (14.1)]. Ganciclovir for Injection, USP is indicated for the prevention of CMV disease in adult transplant recipients at risk for CMV disease [see Clinical Studies (14.2)].

GARDASIL® is a vaccine indicated in girls and women 9 through 26 years of age for the prevention of the following diseases caused by Human Papillomavirus (HPV) types included in the vaccine: And the following precancerous or dysplastic lesions caused by HPV types 6, 11, 16, and 18: GARDASIL is indicated in boys and men 9 through 26 years of age for the prevention of the following diseases caused by HPV types included in the vaccine: And the following precancerous or dysplastic lesions caused by HPV types 6, 11, 16, and 18: The health care provider should inform the patient, parent, or guardian that vaccination does not eliminate the necessity for women to continue to undergo recommended cervical cancer screening. Women who receive GARDASIL should continue to undergo cervical cancer screening per standard of care. [See Patient Counseling Information (17).] Recipients of GARDASIL should not discontinue anal cancer screening if it has been recommended by a health care provider. [See Patient Counseling Information (17).] GARDASIL has not been demonstrated to provide protection against disease from vaccine and non-vaccine HPV types to which a person has previously been exposed through sexual activity. [See Clinical Studies (14.4, 14.5).] GARDASIL is not intended to be used for treatment of active external genital lesions; cervical, vulvar, vaginal, and anal cancers; CIN; VIN; VaIN; or AIN. GARDASIL has not been demonstrated to protect against diseases due to HPV types not contained in the vaccine. [See Clinical Studies (14.4, 14.5).] Not all vulvar, vaginal, and anal cancers are caused by HPV, and GARDASIL protects only against those vulvar, vaginal, and anal cancers caused by HPV 16 and 18. GARDASIL does not protect against genital diseases not caused by HPV. Vaccination with GARDASIL may not result in protection in all vaccine recipients. GARDASIL has not been demonstrated to prevent HPV-related CIN 2/3 or worse in women older than 26 years of age. [See Clinical Studies (14.7).]

Garlic is an herb also known as Ail, Ajo, Allii Sativi Bulbus, Allium, Allium sativum, Camphor of the Poor, Da Suan, Lasun, Lasuna, Nectar of the Gods, Poor Man's Treacle, Rason, Rust Treacle, or Stinking Rose. Garlic is a commonly used food and flavoring agent. When used as a food product, garlic is not likely to produce health benefits or side effects. When used as a medicinal product, garlic may produce both desired and unwanted effects on the body. Garlic products sold as health supplements may vary widely in amount of allicin, the active ingredient in garlic. Allicin is unstable and can be reduced in garlic products that are aged to reduce odor. Odorless garlic may contain little to no allicin. The lower the amount of allicin, the less effective a garlic product might be. Garlic taken orally (by mouth) has been used in alternative medicine as a possibly effective aid in treating high blood pressure, coronary artery disease (hardened arteries), stomach cancer, colon cancer or rectal cancer, and in preventing tick bites. Garlic applied to the skin may also be possibly effective in treating fungal skin infections such as ringworm, jock itch, or athlete's foot. Garlic has also been used to treat high cholesterol, stomach ulcers caused by H. pylori, cancer, or circulation problems in the legs. However, research has shown that garlic may not be effective in treating these conditions. Other uses not proven with research have included preventing the common cold, and improving urination problems caused by an enlarged prostate. It is not certain whether garlic is effective in treating any medical condition. Medicinal use of this product has not been approved by the FDA. Garlic should not be used in place of medication prescribed for you by your doctor. Garlic is often sold as an herbal supplement. There are no regulated manufacturing standards in place for many herbal compounds and some marketed supplements have been found to be contaminated with toxic metals or other drugs. Herbal/health supplements should be purchased from a reliable source to minimize the risk of contamination. Garlic may also be used for purposes not listed in this product guide.

Gas-X is used to relieve painful pressure caused by excess gas in the stomach and intestines. This medicine is for use in babies, children, and adults. Gas-X may also be used for purposes not listed in this medication guide.

GaviLyte-G is indicated for bowel cleansing prior to colonoscopy and barium enema X-ray examination in adults.

Gaviscon are antacids that can lower the acidity of stomach acid. Gaviscon is a combination medicine that is used to treat heartburn, acid indigestion, sour stomach, or upset stomach. .Gaviscon is also used to provide temporary relief from heartburn and acid indigestion caused by acid reflux. Gaviscon may also be used for purposes not listed in this medication guide.

Gavreto (pralsetinib) is a tyrosine kinase inhibitor that may be used to treat adults with non-small cell lung cancer (NSCLC) that has spread to other parts of the body (metastatic). It is only used if your cancer has a specific genetic marker (an abnormal "RET" gene fusion). Your doctor will test you for this gene fusion using an FDA-approved test. Gavreto is also used to treat adults and children 12 years of age and older with advanced or metastatic RET fusion-positive thyroid cancer who require a medicine by mouth or injection (systemic therapy) and who are radioactive iodine-refractory (in cases where radioactive iodine is appropriate). Gavreto was first FDA approved on September 4, 2020, on an "accelerated" basis for metastatic RET fusion-positive NSCLC, and it received accelerated approval for metastatic RET fusion-positive thyroid cancer on December 1, 2020. On 9 August 2023, it received full approval for metastatic RET fusion-positive NSCLC.

Gazyva is a monoclonal antibody that affects the actions of the body's immune system. Obinutuzumab strengthens your immune system to help your body fight against tumor cells. Gazyva is used in combination with another cancer medicine called chlorambucil to treat chronic lymphocytic leukemia. Gazyva is also used in combination with other cancer medicines to treat follicular lymphoma (a type of non-Hodgkin lymphoma), or to help delay the progression of this disease.

Gemcitabine is used to treat cancers of the pancreas, lung, ovary, and breast. Gemcitabine is sometimes given with other cancer medicines, or when other cancer treatments did not work or have stopped working. Gemcitabine may also be used for purposes not listed in this medication guide.

Gemfibrozil helps reduce cholesterol and triglycerides (fatty acids) in the blood. High levels of these types of fat in the blood are associated with an increased risk of atherosclerosis (clogged arteries). Gemfibrozil is used together with diet to treat very high cholesterol and triglyceride levels in people with pancreatitis. Gemfibrozil is also used to lower the risk of stroke, heart attack, or other heart complications in certain people with high cholesterol and triglycerides who have not been helped by other treatment methods.

Gemtesa tablets are used to treat overactive bladder (OAB) symptoms including urinary urgency, urinary frequency, and urge incontinence, which is when you have a strong need to urinate with leaking or wetting accidents. Gemtesa works by relaxing the bladder muscle so it can hold more urine, this may also reduce the urgent need to use the bathroom and may reduce the number of urinary leakages you have.  Gemtesa is a once-daily tablet that can be taken with or without food.  Gemtesa (vibegron) received FDA approval on December 23, 2020, to treat adults with overactive bladder symptoms of urge urinary incontinence, urgency, and urinary frequency. It is from a group of medications called beta-3 agonists.

Genotropin is a form of human growth hormone important for the growth of bones and muscles. Genotropin is used to treat growth failure in children and adults who lack natural growth hormone. This includes people with short stature due to Turner syndrome, Prader-Willi syndrome, short stature at birth with no catch-up growth, and other causes. Genotropin may also be used for purposes not listed in this medication guide.

Gentamicin is an antibiotic that fights bacteria. Gentamicin is used to treat severe or serious bacterial infections. Gentamicin may also be used for purposes not listed in this medication guide.

Genvoya is a tablet containing a combination of cobicistat, elvitegravir, emtricitabine, and tenofovir. Cobicistat reduces the action of enzymes in your liver that break down certain antiviral medicines. This allows the antiviral medicines to be used more safely and effectively at lower doses. Elvitegravir, emtricitabine and tenofovir are antiviral medicines that prevent human immunodeficiency virus (HIV) from multiplying in your body. HIV can cause acquired immunodeficiency syndrome (AIDS). Genvoya is used to treat HIV in adults and children who are at least 12 years old and who weigh at least 55 pounds (25 kilograms). Genvoya is not a cure for HIV or AIDS.

Geodon is an antipsychotic medication. It works by changing the effects of chemicals in the brain. Geodon is used to treat schizophrenia and the manic symptoms of bipolar disorder (manic depression) in adults and children who are at least 10 years old. It is available as an oral (by mouth) treatment as an injection. Geodon injection is used to quickly treat agitation in people with schizophrenia.

The Colazal brand of balsalazide is used to treat mild to moderate active ulcerative colitis in adults and children who are at least 5 years old. The Giazo brand of balsalazide is used to treat mild to moderate active ulcerative colitis in men who are at least 18 years old. Giazo may also be used for purposes not listed in this medication guide.

Gilenya (fingolimod) belongs to a class of medications called sphingosine l-phosphate receptor modulators. Fingolimod works by decreasing the action of immune cells that may cause nerve damage. Gilenya is used to prevent episodes of symptoms and slow the worsening of disability in adults and children 10 years of age and older with relapsing-remitting forms (course of disease where symptoms flare up from time to time) of multiple sclerosis (MS; a disease in which the nerves do not function properly and people may experience weakness, numbness, loss of muscle coordination, and problems with vision, speech, and bladder control). It is taken by mouth (orally). Gilenya will not cure MS, it will only decrease the frequency of relapse symptoms. Gilenya was FDA-approved on September 21, 2010.

Ginger is an herb also known as Amomum Zingiber, Ardraka, Black Ginger, Cochin Ginger, Gan Jiang, Gingembre, Ginger Essential Oil, Ginger Root, Imber, Jengibre, Jiang, Kankyo, Kanshokyo, Nagara, Race Ginger, Racine de Gingembre, Rhizoma Zingiberi, Rhizoma Zingiberis Recens, Sheng Jiang, Shoga, Shokyo, Shunthi, Srungavera, Sunth, Sunthi, Vishvabheshaja, and other names. Ginger has been used in alternative medicine as a possibly effective aid in treating nausea and vomiting caused by taking HIV/AIDS medications or nausea and vomiting associated with pregnancy, menstrual pain, or joint pain caused by osteoarthritis. Ginger has also been used to treat or prevent motion sickness, and muscle pain after exercise. However, research has shown that ginger may not be effective in treating these conditions. Other uses not proven with research have included alcohol hangover, migraine headaches, nausea and vomiting due to chemotherapy, trouble swallowing, high cholesterol, rheumatoid arthritis, insect bite, dry mouth, inflammatory bowel disease, hypertension, indigestion, and other conditions. It is not certain whether ginger is effective in treating any medical condition. Medicinal use of this product has not been approved by the FDA. Ginger should not be used in place of medication prescribed for you by your doctor. Ginger is often sold as an herbal supplement. There are no regulated manufacturing standards in place for many herbal compounds and some marketed supplements have been found to be contaminated with toxic metals or other drugs. Herbal/health supplements should be purchased from a reliable source to minimize the risk of contamination. Ginger may also be used for purposes not listed in this product guide.

Ginkgo Biloba is a plant also known as Maidenhair tree, Ginkgo Biloba biloba, Abricot Argente Japonais, Adiantifolia, Arbre aux Ecus, Arbre du Ciel, Arbre Fossile, Bai Guo Ye, Baiguo, Extrait de Ginkgo Biloba, Fossil Tree, Graine de Ginkgo Biloba, Herba Ginkgo Biloba Biloba, Japanese Silver Apricot, Kew Tree, Noyer du Japon, Pei Go Su Ye, Salisburia Adiantifolia, Yen Xing, Yinhsing, Arbe aux Quarante Ecus, Extrait de Feuille de Ginkgo Biloba, Ginkgo Biloba Folium and other names. Ginkgo Biloba has been used in alternative medicine as a possibly effective aid in treating anxiety, certain types of dementia, premenstrual symptoms, vertigo (dizziness), stroke, schizophrenia, or a movement disorder (tardive dyskinesia) caused by taking certain antipsychotic drugs. Ginkgo Biloba has also been used to treat memory problems, tinnitus (ringing in the ears), high blood pressure, multiple sclerosis, heart disease, and sexual problems caused by taking antidepressants. However, research has shown that Ginkgo Biloba may not be effective in treating these conditions. Other uses not proven with research have included altitude sickness, macular degeneration (age-related vision loss), attention deficit disorder, dyslexia, vitiligo (discolored skin), migraine, lung disease, high cholesterol, Raynaud's syndrome, Lyme disease, fibromyalgia, chronic fatigue syndrome, blood clots, seasonal allergy, leg pain caused by blood circulation problems, cough, depression, sexual dysfunction in females, asthma, autism spectrum disorder, chronic kidney disease, cocaine dependence, vision problems, hemorrhoids, intestinal parasite infection, wound healing, and certain type of cancers. It is not certain whether Ginkgo Biloba is effective in treating any medical condition. Medicinal use of this product has not been approved by the FDA. Ginkgo Biloba should not be used in place of medication prescribed for you by your doctor. Ginkgo Biloba is often sold as an herbal supplement. There are no regulated manufacturing standards in place for many herbal compounds and some marketed supplements have been found to be contaminated with toxic metals or other drugs. Herbal/health supplements should be purchased from a reliable source to minimize the risk of contamination. Ginkgo Biloba may also be used for purposes not listed in this product guide.

Ginseng is used by some people as medicine. Science does not support the use of this product for any health problem.

Glatiramer injection is used to treat relapsing-forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. This medicine will not cure multiple sclerosis, but may extend the time between relapses. This medicine is available only with your doctor's prescription.

Gleevec is a targeted therapy cancer treatment used to treat specific types of leukemia (blood cancer), bone marrow disorders, skin cancers and certain tumors of the stomach and digestive system. Gleevec (imatinib) is an oral tablet that is taken once or twice a day. Gleevec works by interfering with specific proteins that help tumors grow and spread through the body; they come from the family of medicines called BCR-ABL tyrosine kinase inhibitors. Gleevec was a groundbreaking cancer treatment when it was first FDA approved on May 10, 2001. Gleevec is used to treat specific types of these cancers: Gleevec (imatinib) is now available as a generic.

Glimepiride is an oral diabetes medicine that is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. glimepiride is not for treating type 1 diabetes. Glimepiride may also be used for purposes not listed in this medication guide.

Glipizide is an oral diabetes medicine that helps control blood sugar levels by helping your pancreas produce insulin. Glipizide is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. Glipizide is not for treating type 1 diabetes.

Glucagon is a hormone that increases blood sugar levels. It also slows involuntary muscle movements of the stomach and intestines that aid in digestion. Glucagon injection is a prescription medicine used to treat very low blood sugar (hypoglycemia). Glucagon is also used to stop stomach movement during radiologic (x-ray) examinations undertaken to diagnose certain disorders of the stomach or intestines. Glucagon is available as an auto-injector, prefilled syringe, or injection vial.

Glucophage is an oral diabetes medicine that helps control blood sugar levels. Glucophage is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. Glucophage is sometimes used together with insulin or other medications, but metformin is not for treating type 1 diabetes.

Glucosamine is sugar protein that helps your body build cartilage (the hard connective tissue located mainly on the bones near your joints). Glucosamine is a naturally occurring substance found in bones, bone marrow, shellfish and fungus. Glucosamine has been used in alternative medicine as an aid to relieving joint pain, swelling, and stiffness caused by arthritis. Not all uses for glucosamine have been approved by the FDA. Glucosamine should not be used in place of medication prescribed for you by your doctor. Glucosamine is often sold as an herbal supplement. There are no regulated manufacturing standards in place for many herbal compounds and some marketed supplements have been found to be contaminated with toxic metals or other drugs. Herbal/health supplements should be purchased from a reliable source to minimize the risk of contamination. Glucosamine may also be used for purposes not listed in this product guide.

Glucotrol is an oral diabetes medicine that helps control blood sugar levels by helping your pancreas produce insulin. Glucotrol is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. Glucotrol is not for treating type 1 diabetes.

Glutathione is used by some people as medicine. Science does not support the use of this product for any health problem.

Glyburide is an oral diabetes medicine that helps control blood sugar levels. Glyburide is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. Glyburide is not for treating type 1 diabetes.

Glycerin , when taken by mouth, is used to treat certain conditions in which there is increased eye pressure, such as glaucoma. It may also be used before eye surgery to reduce pressure in the eye. Glycerin may also be used for other conditions as determined by your doctor. This medicine is available only with your doctor's prescription.

GlycoLax is a laxative solution that increases the amount of water in the intestinal tract to stimulate bowel movements. GlycoLax is used as a laxative to treat occasional constipation or irregular bowel movements. GlycoLax may also be used for purposes not listed in this medication guide.

Glycopyrrolate helps to control conditions such as peptic ulcers that involve excessive stomach acid production. Glycopyrrolate is also used to reduce drooling in children ages 3 to 16 who have certain medical conditions, such as cerebral palsy. Glycopyrrolate injection is also used during surgery to reduce secretions in your stomach or airway, and to help protect your heart and nervous system while you are under general anesthesia. Glycopyrrolate may also be used for purposes not listed in this medication guide.

Glyxambi contains a combination of empagliflozin and linagliptin. Empagliflozin and linagliptin are oral diabetes medicines that help control blood sugar levels. Empagliflozin works by helping the kidneys get rid of glucose from your bloodstream. Linagliptin works by regulating the levels of insulin your body produces after eating. Glyxambi is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. Glyxambi is also used to lower the risk of death from heart attack, stroke, or heart failure in adults with type 2 diabetes who also have heart disease. This medicine is not for treating type 1 diabetes.

Gocovri is a prescription medicine containing amantadine. Gocovri is used to treat dyskinesia (sudden uncontrolled movements) in people with Parkinson's disease who are treated with levodopa or levodopa plus other medicines that increase the effects of dopamine in the brain. Gocovri is also used with the medicines levodopa and carbidopa in people with Parkinson’s disease who are having “off” episodes. Gocovri may also be used for purposes not listed in this medication guide.

GoLYTELY is a laxative solution that stimulates bowel movements. This medication also contains minerals to replace electrolytes that are passed from the body in the stool. GoLYTELY is used to clean the bowel before colonoscopy, a barium x-ray, or other intestinal procedures. GoLYTELY may also be used for purposes not listed in this medication guide.

Palliative treatment of advanced prostate cancer. Considered one of several first-line options for hormonal therapy; other options include orchiectomy, estrogens, and antiandrogens. In clinical studies, goserelin (3.6 mg every 4 weeks) was as effective as orchiectomy. Clinical outcome in patients receiving goserelin 10.8 mg every 12 weeks expected to be similar to that of patients receiving goserelin 3.6 mg every 4 weeks. Also used as an adjunct to radiation therapy in patients with stage III [C]) prostate cancer. Treatment of locally confined stage T2b-T4 (B2-C) prostate cancer in conjunction with flutamide and radiation therapy. Palliative treatment of endometriosis. Experience with goserelin has been limited to women ≥18 years of age who received consecutive therapy (3.6 mg every 4 weeks) for 6 months. Palliative treatment of advanced breast cancer in premenopausal and perimenopausal women. Use of ovarian suppression in combination with endocrine therapy (i.e., anastrozole, exemestane, letrozole, tamoxifen)† [off-label] as adjuvant therapy† [off-label] in premenopausal women with early-stage hormone receptor-positive breast cancer† [off-label] may be considered a reasonable choice (accepted). Used as an endometrial-thinning agent prior to endometrial ablation procedures for the treatment of dysfunctional uterine bleeding.

Granisetron blocks the actions of chemicals in the body that can trigger nausea and vomiting. Granisetron is used to prevent nausea and vomiting that may be caused by medicine to treat cancer (chemotherapy or radiation). Granisetron may also be used for purposes not listed in this medication guide.

Griseofulvin is an antifungal medicine that is used to treat infections such as ringworm, athlete's foot, jock itch, and fungal infections of the scalp, fingernails, or toenails. Griseofulvin may also be used for purposes not listed in this medication guide.

Guaifenesin is an ingredient in cough and cold medicines that is used to help clear mucus or phlegm from your chest when you have had a cold or flu. Guaifenesin works by making your mucus thinner and easier to cough up, which helps clear chest congestion. Guaifenesin is available as an over-the-counter (OTC) medicine and also available on prescription. Guaifenesin is not FDA approved for treatment of fibromyalgia but some people take it off-label for this condition.  In clinical studies guaifenesin has not shown to be effective for fibromyalgia.

Guanfacine is used to treat high blood pressure (hypertension). It is sometimes given with other blood pressure medications. The Intuniv brand of guanfacine is used to treat attention deficit hyperactivity disorder (ADHD). Guanfacine may also be used for purposes not listed in this medication guide.

Gvoke is a hormone that increases blood sugar levels. Gvoke is used to treat hypoglycemia (low blood sugar). Gvoke in the HypoPen auto-injector, pre-filled syringe (PFS), and the vial and syringe kit is given by subcutaneous (under the skin) injection. Gvoke is for use in adults and children (aged 2 years and above) with diabetes.

Haegarda is a man-made form of a protein in blood that helps control swelling in the body. People with a condition called Hereditary Angioedema (HAE) do not have enough of this protein. Hereditary Angioedema can cause attacks of swelling and symptoms such as stomach problems or trouble breathing. Haegarda is an injectable medicine used to prevent swelling and/or painful attacks in patients 6 years of age and older with Hereditary Angioedema. Haegarda should not be used to treat an acute HAE attack. In case of an acute HAE attack, initiate individualized treatment as discussed with your health care professional.

Haldol is an antipsychotic medicine that is used to treat schizophrenia. Haldol is also used to control motor and speech tics in people with Tourette's syndrome. Haldol may also be used for purposes not listed in this medication guide.

Halobetasol topical is a super high potency, Class I corticosteroid product that is applied to the skin to reduce inflammation and itching caused by plaque psoriasis or other skin conditions that respond to corticosteroid medication. Halobetasol topical is available as a cream, ointment, lotion, or foam:

Haloperidol is an antipsychotic medicine that is used to treat schizophrenia. Haloperidol is also used to control motor and speech tics in people with Tourette's syndrome. Haloperidol may also be used for purposes not listed in this medication guide.

Harvoni is an oral, 2-drug antiviral treatment containing ledipasvir and sofosbuvir that may be used to treat adults and children aged 3 years and older with chronic (long-lasting) hepatitis C (HCV): Your doctor will perform tests to find out which hepatitis genotype you have. The 2 antivirals in Harvoni each have a different mechanism of action. Ledipasvir blocks the effects of an HCV protein called NS5A which is required for the virus to multiply (called viral replication). Harvoni also contains sofosbuvir, a prodrug, that is converted in the body to its active metabolite which uses an enzyme called NS5B RNA polymerase to incorporate itself into HCV RNA and acts as a chain terminator. This also prevents the virus from making copies of itself. Harvoni was FDA-approved on October 10, 2014. One strength of Harvoni is available as a generic: Harvoni 90 mg/400 mg (ledipasvir 90 mg/sofosbuvir 400 mg). Harvoni 45 mg/200 mg and Harvoni oral pellets are not available as generics.

Human chorionic gonadotropin (HCG) is a hormone that supports the normal development of an egg in a woman's ovary, and stimulates the release of the egg during ovulation. HCG is used to cause ovulation and to treat infertility in women, and to increase sperm count in men. HCG is also used in young boys when their testicles have not dropped down into the scrotum normally. This can be caused by a pituitary gland disorder. HCG may also be used for other purposes not listed.

Hemgenix is a one-time gene therapy for the treatment of adults with hemophilia B. Hemophilia B is an inherited bleeding disorder resulting from missing or insufficient levels of blood clotting Factor IX, a protein needed to produce blood clots to stop bleeding. Hemgenix consists of a viral vector that carries a gene for Factor IX. The gene is expressed in the liver to produce the Factor IX protein, which increases the blood levels of Factor IX to limit episodes of bleeding. 

Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots caused by certain medical conditions or medical procedures. It is also used before surgery to reduce the risk of blood clots. Do not use heparin injection to flush (clean out) an intravenous (IV) catheter. A separate product is available to use as catheter lock flush. Using the wrong type of heparin to flush a catheter can result in fatal bleeding.

Treatment of DVT and PE. Recommended by the American College of Chest Physicians (ACCP) as an appropriate choice of anticoagulant for initial treatment of acute proximal DVT or PE. LMWHs or fondaparinux generally preferred over heparin for initial treatment of acute venous thromboembolism; however, heparin may be preferred in patients with renal impairment. IV heparin also may be preferred over sub-Q therapies in patients with PE in whom thrombolytic therapy is being considered or if there is concern about adequate sub-Q absorption. After full-dose heparin therapy, warfarin or an LMWH generally is administered as follow-up anticoagulant therapy for ≥3 months in adults with venous thromboembolism. Prophylaxis of postoperative DVT and PE in patients undergoing general (e.g., abdominal) surgery who are at risk of thromboembolism. ACCP recommends pharmacologic (e.g., low-dose heparin) and/or nonpharmacologic/mechanical (e.g., intermittent pneumatic compression) methods of thromboprophylaxis in patients undergoing general surgery, including abdominal, GI, gynecologic, and urologic surgery, according to the patient’s risk of thromboembolism and bleeding. In general, pharmacologic prophylaxis is recommended in patients with high (and possibly moderate) risk of venous thromboembolism who do not have a high risk of bleeding, while mechanical methods are suggested in patients who require thromboprophylaxis but have a high risk of bleeding. If pharmacologic prophylaxis is indicated in patients undergoing general surgery, ACCP states that an LMWH or low-dose heparin is preferred. ACCP states that the same recommendations for use of antithrombotic agents in general surgery patients can be applied to patients undergoing bariatric, vascular, and plastic/reconstructive surgery. Mechanical methods of prophylaxis generally recommended in patients undergoing cardiac surgery; however, ACCP states that low-dose heparin may be considered in cardiac surgery patients with a complicated postoperative course. Has been used for prevention of venous thromboembolism in patients undergoing craniotomy† [off-label]; however, benefits may be outweighed by possible increased risk of intracranial hemorrhage. ACCP states that the addition of low-dose heparin to a mechanical method of prophylaxis may be considered in patients at very high risk of thromboembolism (e.g., those undergoing craniotomy for malignant disease) once adequate hemostasis established and risk of bleeding decreases. Also may be considered as a possible addition to mechanical prophylaxis in high-risk patients undergoing spinal surgery† [off-label] (e.g., those with malignancy or those undergoing surgery with a combined anterior-posterior approach) once adequate hemostasis established and risk of bleeding decreases. Prevention of postoperative DVT and PE in patients undergoing major thoracic surgery. Pharmacologic thromboprophylaxis (e.g., low-dose heparin) recommended by ACCP in patients undergoing thoracic surgery who are at high risk of venous thromboembolism, provided risk of bleeding is low. Has been used for prevention of DVT and PE in patients undergoing total hip-replacement surgery† [off-label], total knee-replacement surgery† [off-label], or hip-fracture surgery† [off-label]. ACCP recommends routine thromboprophylaxis (with a pharmacologic and/or mechanical method) in all patients undergoing major orthopedic surgery because of high risk of postoperative venous thromboembolism; continue thromboprophylaxis for at least 10–14 days, and possibly for up to 35 days after surgery. Among several antithrombotic agents (e.g., LMWH, fondaparinux, low-dose heparin, warfarin, aspirin) recommended for pharmacologic thromboprophylaxis in patients undergoing major orthopedic surgery, ACCP states LMWHs generally preferred; may consider alternative agents when an LMWH is not available or cannot be used. When selecting an appropriate thromboprophylaxis regimen, consider factors such as relative efficacy and safety of the drugs in addition to other logistics and compliance issues. Used for prevention of DVT and PE in acutely ill hospitalized medical patients and in those with medical conditions associated with a high risk of thromboembolism (e.g., cancer). In general, pharmacologic thromboprophylaxis recommended only in patients considered to be at high risk of venous thromboembolism. ACCP recommends anticoagulant prophylaxis (e.g., low-dose heparin) in acutely ill, hospitalized medical patients at increased risk of thrombosis who are not actively bleeding and do not have an increased risk of bleeding. Continued thromboprophylaxis suggested for 6–21 days until full mobility is restored or hospital discharge. Low-dose heparin also suggested by ACCP for pharmacologic thromboprophylaxis in critically ill patients (e.g., those in an intensive care unit [ICU]) who are not actively bleeding and do not have risk factors for bleeding. Risk of venous thromboembolism is particularly high in patients with cancer. Use of low-dose heparin suggested by ACCP in cancer (solid tumors) outpatients who have additional risk factors for thromboembolism, provided risk of bleeding is low. Low-dose heparin may be used for thromboprophylaxis in patients with major trauma†. For major trauma patients at high risk of venous thromboembolism, including those with acute spinal cord injury, traumatic brain injury, or spinal surgery for trauma, ACCP suggests the use of both a pharmacologic and mechanical method of prophylaxis, unless contraindications exist. Has been used for prevention and treatment of venous thromboembolism during pregnancy; however, an LMWH generally is recommended by ACCP because of a more favorable safety profile. Has been used in combination with low-dose aspirin for prevention of recurrent pregnancy loss in women with antiphospholipid antibodies (APLA) syndrome†. Also has been used with aspirin (often combined with immune globulin) for prevention of venous thromboembolism and early pregnancy loss in women who have undergone in vitro fertilization†. Has been used for treatment and secondary prevention of venous thromboembolism in neonates and children†; venous thromboembolism usually occurs secondary to an identifiable risk factor (e.g., presence of central venous access device) in such patients. Recommendations regarding use of antithrombotic therapy in children generally based on extrapolation from adult guidelines. In children with central venous catheters (or umbilical venous catheters) who experience venous thromboembolism, ACCP recommends removal of catheter if no longer functioning or required; at least 3–5 days of therapeutic anticoagulation suggested prior to removal. If such catheters must remain in place, ACCP suggests anticoagulant therapy until catheter is removed. Has been used to reduce the risk of stroke and systemic embolism in patients undergoing electrical or pharmacologic cardioversion† for atrial fibrillation or atrial flutter. Therapeutic anticoagulation with heparin may be used in patients in whom prolonged anticoagulation (e.g., with warfarin for ≥3 weeks) prior to cardioversion is not necessary or not possible; in these situations, heparin or an LMWH generally is administered at the time of transesophageal echocardiograph (TEE) or at presentation (for those with atrial fibrillation ≤48 hours) just prior to cardioversion. In patients with hemodynamic instability who require urgent cardioversion, ACCP suggests administration of IV heparin or an LMWH prior to cardioversion, if possible; however, such anticoagulant therapy must not delay any emergency intervention. Used during conversion to maintenance warfarin therapy to reduce the incidence of thromboembolism (e.g., stroke) in patients with prosthetic mechanical heart valves†. ACCP suggests bridging anticoagulation (administration of an LMWH in either prophylactic or therapeutic dosages or IV heparin in prophylactic dosages) during the early postoperative period after insertion of a mechanical heart valve until patient is stable on warfarin therapy. Also may be used for bridging anticoagulation in patients with a mechanical heart valve in whom therapy with warfarin must be temporarily discontinued (e.g., for major surgery). ACC and AHA state that perioperative use of heparin should be considered for noncardiac surgery, invasive procedures, or dental procedures in patients with prosthetic heart valves who are at high risk for thrombosis without oral antithrombotic therapy (e.g., those with any mechanical mitral valve or a mechanical aortic valve with additional risk factors). Used for thromboprophylaxis in pregnant women with prosthetic mechanical heart valves†. (See Thromboembolism During Pregnancy under Dosage and Administration.) Renal vein thrombosis† is the most common cause of spontaneous venous thromboembolism in neonates. Although use of anticoagulant therapy in patients with renal vein thrombosis is controversial, heparin is suggested by ACCP as a possible treatment option in selected neonates. Used to reduce the extent of ischemic injury in patients with acute arterial emboli or thrombosis; however, ACCP states formal studies demonstrating improved outcomes have not been conducted. In patients with limb ischemia secondary to arterial emboli or thrombosis, immediate systemic anticoagulation with heparin to prevent thrombotic propagation is suggested by ACCP. Prophylaxis during cardiac catheterization via an artery in neonates and children. If femoral artery thrombosis occurs following cardiac catheterization, therapeutic-dose IV heparin is recommended, followed by subsequent conversion to an LMWH or continued treatment with heparin to complete 5–7 days of therapeutic anticoagulation. Prevention of activation of the coagulation mechanism during arterial and cardiac surgery. A nonheparin anticoagulant (e.g., bivalirudin) may be used in place of heparin in patients with acute heparin-induced thrombocytopenia (HIT) or subacute HIT (platelets have recovered, but HIT antibodies still present) who require urgent cardiac surgery. Because HIT antibodies are transient, ACCP states that short-term use of heparin may be appropriate in patients with a remote (>3 months) history of HIT and no detectable antibodies who require cardiac surgery. Treatment of acute and chronic consumptive coagulopathies, including disseminated intravascular coagulation. Maintenance of patency of indwelling peripheral or central venipuncture devices designed for intermittent injections and/or blood sampling. ACCP suggests use of heparin flushes as an option for primary thromboprophylaxis of central venous access devices in children. In neonates and children with peripheral arterial catheters, ACCP recommends continuous IV infusion of heparin (in low concentrations) via the catheter for prophylaxis. Also may consider use of heparin for treatment if symptomatic catheter-related thromboembolism occurs. In neonates with umbilical arterial catheters, ACCP also suggests thromboprophylaxis with low-dose heparin via the catheter to maintain patency. Used in combination with antiplatelet agents (e.g., aspirin) during and after successful coronary artery reperfusion (e.g., thrombolytic agents) for prevention of ischemic complications of STEMI† (e.g., death, reinfarction, stroke). The American College of Cardiology Foundation (ACCF) and AHA state that patients with STEMI undergoing thrombolytic therapy should receive an anticoagulant (e.g., heparin, enoxaparin, fondaparinux) for ≥48 hours, and preferably for the duration of the index hospitalization, up to 8 days or until revascularization is performed. Enoxaparin is preferred over heparin if extended anticoagulation (>48 hours) is necessary. Used to reduce the risk of thrombotic complications in patients undergoing PCI. Used in conjunction with aspirin and other standard therapy (e.g., GP IIb/IIIa-receptor inhibitors, P2Y12 receptor antagonists). Use of a parenteral anticoagulant is recommended in patients undergoing PCI to prevent thrombus formation during the procedure. IV heparin is recommended by AHA, the American College of Cardiology Foundation (ACCF), and the Society for Cardiovascular Angiography and Interventions (SCAI) as an appropriate choice of anticoagulant. Reduction in the risk of acute cardiac ischemic events (death and/or MI) in patients with NSTE ACS (unstable angina or non-ST-segment-elevation MI [NSTEMI])†. Used concurrently with aspirin and/or other standard therapy (e.g., nitrates, β-adrenergic blocking agents [β-blockers], P2Y12 receptor antagonists). Initial parenteral anticoagulants with established efficacy in patients with NSTE ACS include enoxaparin, heparin, bivalirudin (only in patients managed with an early invasive strategy), and fondaparinux. In patients who will undergo CABG, if heparin is already being administered, continue during surgery. If patient is receiving other anticoagulants (enoxaparin, fondaparinux, or bivalirudin), discontinue other anticoagulant and use heparin during CABG. In patients in whom conservative medical therapy is selected as a postangiographic management strategy, recommendations for continued antiplatelet and anticoagulant therapy generally are based on the presence of CAD. May be used for treatment of acute cerebral venous sinus (sinovenous) thrombosis† in adults. May convert to oral anticoagulant therapy once patient is stabilized. Recommended by ACCP as an option for initial anticoagulation in children with cerebral venous sinus thrombosis† without substantial intracranial hemorrhage. Also has been suggested for use in such children with substantial hemorrhage. Heparin anticoagulants (i.e., LMWH or heparin) have been used for thromboprophylaxis in selected patients with acute ischemic stroke†; those with additional risk factors for venous thromboembolism are more likely to benefit. ACCP suggests thromboprophylaxis with an LMWH (in prophylactic dosages), sub-Q heparin, or intermittent pneumatic compression in patients with acute ischemic stroke† and restricted mobility; LMWH is preferred over heparin. Prophylactic-dose heparin usually initiated within 48 hours of onset of stroke and continued throughout hospital stay until patient regains mobility; do not administer within the first 24 hours after thrombolytic therapy. Also has been used for initial management of acute arterial ischemic stroke in children† until dissection and embolic causes have been excluded. In children with acute arterial ischemic stroke secondary to non-Moyamoya vasculopathy†, ACCP recommends ongoing antithrombotic therapy (e.g., heparin) for 3 months. Heparin may be considered in neonates with a first episode of arterial ischemic stroke associated with a documented cardioembolic source. Used in the perioperative management of patients who require temporary interruption of long-term warfarin therapy for surgery or other invasive procedures. ACCP suggests perioperative use of an LMWH or IV heparin (bridging anticoagulation) in selected patients with venous thromboembolism, atrial fibrillation, or mechanical prosthetic heart valves depending on their risk of developing thromboembolism without warfarin therapy. In general, bridging anticoagulation is suggested in such patients who are considered to be at particularly high risk of venous thromboembolism without oral anticoagulant therapy. Used as an in vitro anticoagulant in blood transfusions. Used for anticoagulation during extracorporeal circulation and dialysis procedures.

Hepatitis B is a disease of the liver that is spread through blood or bodily fluids, sexual contact or sharing IV drug needles with an infected person, or during childbirth when the mother is infected. Hepatitis causes inflammation of the liver, vomiting, and jaundice (yellowing of the skin or eyes). Hepatitis can lead to liver cancer, cirrhosis, or death. The hepatitis B vaccine is used to help prevent this disease in adults. This vaccine helps your body develop immunity to the disease, but will not treat an active infection you already have. Vaccination with hepatitis B vaccine is recommended for all adults who are at risk of getting hepatitis B. Like any vaccine, the hepatitis B vaccine may not provide protection from disease in every person.

Herceptin is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Herceptin is used to treat certain types of breast cancer or stomach cancer. Other cancer medicines are sometimes used in combination with Herceptin. Herceptin is sometimes used when the cancer has spread to other parts of the body (metastatic).

Chlorhexidine is an antiseptic that fights bacteria. Hibiclens (for the skin) is used to clean the skin to prevent infection that may be caused by surgery, injection, or skin injury. Hibiclens may also be used for purposes not listed in this medication guide.

Hiprex is an antibacterial medicine used to treat or prevent bladder infections in adults and children at least 6 years old. Hiprex may also be used for purposes not listed in this medication guide.

Histrelin overstimulates the body's own production of certain hormones, which causes that production to shut down temporarily. The Supprelin LA brand of histrelin is used to treat precocious puberty in both male and female children who are at least 2 years old. The Vantas brand of histrelin is used to treat symptoms of prostate cancer in men. Vantas treats only the symptoms of prostate cancer but does not treat the cancer itself. Histrelin may also be used for purposes not listed in this medication guide.

Hizentra is a sterilized solution made from human plasma. It contains the antibodies to help your body protect itself against infection from various diseases. Hizentra subcutaneous infusion (for injection under the skin) is used to treat primary immunodeficiency diseases. This includes, but is not limited to, the humoral immune defect in congenital agammaglobulinemia, common variable immunodeficiency, X-linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies. Hizentra infusion is also used to treat chronic inflammatory demyelinating polyneuropathy (an autoimmune disorder in which the immune system attacks the nerves, causing muscle weakness and numbness).

Horizant is a prescription medicine used to treat adults with restless legs syndrome and pain from damaged nerves. It affects chemicals and nerves in the body that are involved in the cause of some types of pain. Horizant is used in adults to treat nerve pain (postherpetic neuralgia) caused by herpes virus or shingles (herpes zoster). Horizant is also used to treat restless legs syndrome (RLS). Use only the brand and form of gabapentin your doctor has prescribed. Check your medicine each time you get a refill to make sure you receive the correct form.

Humalog is a fast-acting insulin that starts to work about 15 minutes after injection, peaks in about 1 hour, and keeps working for 2 to 4 hours. Insulin is a hormone that works by lowering levels of glucose (sugar) in the blood. Humalog is used to improve blood sugar control in adults and children with diabetes mellitus. Humalog is used to treat type 2 diabetes in adults. Humalog is also used to treat type 1 diabetes in adults and children who are at least 3 years old.

Humira is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira is used to treat many inflammatory conditions in adults, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa. Humira is also used in adults and children to treat Crohn's disease, juvenile idiopathic arthritis, ulcerative colitis and uveitis.

Humulin N is a man-made form of a hormone that is produced in the body. Insulin is a hormone that works by lowering levels of glucose (sugar) in the blood. Insulin isophane is an intermediate-acting insulin that starts to work within 2 to 4 hours after injection, peaks in 4 to 12 hours, and keeps working for 12 to 18 hours. Humulin N is used to improve blood sugar control in adults and children with diabetes mellitus. Humulin N may also be used for purposes not listed in this medication guide.

Insulin is a hormone that works by lowering levels of glucose (sugar) in the blood. Humulin R is a short-acting insulin that starts to work within 30 minutes after injection, peaks in 2 to 3 hours, and keeps working for up to 8 hours. Humulin R is used to improve blood sugar control in adults and children with diabetes mellitus. Humulin R may be used for type 1 or type 2 diabetes.

Insulin is a hormone that works by lowering levels of glucose (sugar) in the blood. Concentrated (U-500) insulin is a long-acting insulin that starts to work several hours after injection and keeps working evenly for 24 hours. U-500 insulin is five times more concentrated than regular U-100 insulin. U-500 insulin is used to improve blood sugar control in adults and children with diabetes mellitus who have significant daily insulin needs (more than 200 units per day). U-500 insulin may also be used for purposes not listed in this medication guide.

Hydralazine is a vasodilator that works by relaxing the muscles in your blood vessels to help them dilate (widen). This lowers blood pressure and allows blood to flow more easily through your veins and arteries. Hydralazine is used to treat high blood pressure (hypertension). Hydralazine may also be used for purposes not listed in this medication guide.

Hydrea is used to treat chronic myeloid leukemia, ovarian cancer, and certain types of skin cancer (squamous cell cancer of the head and neck). Hydrea is also used to reduce pain episodes and the need for blood transfusions in people with sickle cell anemia. This medicine will not cure sickle cell anemia. Hydrea may also be used for purposes not listed in this medication guide.

Hydrochlorothiazide is a thiazide diuretic (water pill) that helps prevent your body from absorbing too much salt, which can cause fluid retention. Hydrochlorothiazide is used to treat high blood pressure (hypertension). Hydrochlorothiazide is also used to treat fluid retention (edema) in people with congestive heart failure, cirrhosis of the liver, or kidney disorders, or edema caused by taking steroids or estrogen.

Hydrochlorothiazide is a thiazide diuretic (water pill). Lisinopril is in an ACE inhibitor (ACE stands for angiotensin converting enzyme). Hydrochlorothiazide and lisinopril is a combination medicine used to treat hypertension (high blood pressure). Lowering blood pressure may lower your risk of a stroke or heart attack. Hydrochlorothiazide and lisinopril may also be used for purposes not listed in this medication guide.

Hydrochlorothiazide is a diuretic (water pill). Losartan is an angiotensin II receptor antagonist (sometimes called an ARB blocker). Hydrochlorothiazide and losartan is a combination medicine used to treat high blood pressure (hypertension). It is also used to lower the risk of stroke in certain people with heart disease. Hydrochlorothiazide and losartan may also be used for purposes not listed in this medication guide.